Insulin-like growth factor receptor 1 (IGFR-1) and outcome measures in advanced non-small cell lung cancer (NSCLC) patients treated with gefitinib

被引：0
|
作者：
Fidler, M. J. [1 ]
Basu, S. [1 ]
Buckingham, L. [1 ]
Kaiser, K. [1 ]
McCormack, S. E. [1 ]
Coon, J. S. [1 ]
Bonomi, P. D. [1 ]
机构：
[1] Rush Univ, Med Ctr, Chicago, IL 60612 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
8036
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Insulin-like growth factor-1 receptor (IGF-1R) as a biomarker for resistance to the tyrosine kinase inhibitor gefitinib in non-small cell lung cancer
    Nir Peled
    Murry W. Wynes
    Norihiko Ikeda
    Tatsuo Ohira
    Koichi Yoshida
    Jin Qian
    Maya Ilouze
    Ronen Brenner
    Yasufumi Kato
    Celine Mascaux
    Fred R. Hirsch
    Cellular Oncology, 2013, 36 : 277 - 288
  • [22] Pretreatment Serum Levels of Insulin-Like Growth Factor 1 and Insulin-Like Growth Factor Binding Protein-3 in Men with Advanced Non-Small Cell Lung Cancer
    Colak, Ayfer
    Diniz, Gulden
    Golcuk, Burcu
    Coker, Isil
    Cirak, A. Kadri
    Unlu, Ismet
    TURKIYE KLINIKLERI TIP BILIMLERI DERGISI, 2012, 32 (04): : 1078 - 1083
  • [23] Celecoxib inhibits insulin-like growth factor 1 induced growth and invasion in non-small cell lung cancer
    Liu, Chen-Hui
    Bao, Hong-Guang
    Ge, Ya-Li
    Wang, Shu-Kui
    Shen, Yan
    Xu, Li
    ONCOLOGY LETTERS, 2013, 5 (06) : 1943 - 1947
  • [24] Insulin-like growth factor-1 receptor-targeted therapy for non-small cell lung cancer: a mini review
    Yin, Ming
    Guan, Xiaoxiang
    Liao, Zhongxin
    Wei, Qingyi
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2009, 1 (02): : 101 - 114
  • [25] Gefitinib in the treatment of elderly patients with advanced non-small cell lung cancer (NSCLC)
    Bearz, Alessandra
    Fratino, Lucia
    Spazzapan, Simon
    Berretta, Massimiliano
    Giacalone, Annalisa
    Simonelli, Cecilia
    Tirelli, Umberto
    LUNG CANCER, 2007, 55 (01) : 125 - 127
  • [26] Serum EGFR in patients with non-small cell lung cancer (NSCLC) treated with gefitinib
    Spreafico, A
    Gregorc, V
    Ludovini, V
    Pistola, L
    Amoroso, M
    Tofanetti, F
    Compagnoni, A
    Aondio, G
    Tonato, M
    Villa, E
    LUNG CANCER, 2005, 49 : S112 - S113
  • [27] Association of plasma hepatocyte growth factor (HGF) and insulin-like growth factor binding protein (IGFBP)-3 with gefitinib resistance in patients with advanced non-small cell lung cancer
    Han, Ji-Youn
    Kim, Jin Young
    Lee, Soo-Hyun
    Lee, Geon Kook
    Lee, Jin Soo
    CANCER RESEARCH, 2011, 71
  • [28] Insulin-like growth factor receptor 1 (IGF1R) expression and survival in surgically resected non-small-cell lung cancer (NSCLC) patients
    Cappuzzo, F.
    Tallini, G.
    Finocchiaro, G.
    Wilson, R. S.
    Ligorio, C.
    Giordano, L.
    Toschi, L.
    Incarbone, M.
    Cavina, R.
    Terracciano, L.
    Roncalli, M.
    Alloisio, M.
    Varella-Garcia, M.
    Franklin, W. A.
    Santoro, A.
    ANNALS OF ONCOLOGY, 2010, 21 (03) : 562 - 567
  • [29] miR-497 may enhance the sensitivity of non-small cell lung cancer cells to gefitinib through targeting the insulin-like growth factor-1 receptor
    Ma, Wei
    Feng, Weiye
    Tan, Jie
    Xu, Airu
    Hue, Yudong
    Nine, Lanlan
    Kang, Yanhong
    Wang, Liuqian
    Zhao, Ziwen
    JOURNAL OF THORACIC DISEASE, 2018, 10 (10) : 5889 - 5897
  • [30] Insulin-like growth factor receptor 1 (IGF1R) expression and survival in non-small cell lung cancer patients: a meta-analysis
    Zhao, Shuang
    Qiu, Zhixin
    He, Jinlan
    Li, Lei
    Li, Weimin
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2014, 7 (10): : 6694 - U904
12345